UNVERIFIEDSingle Source
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News|4/1/2026
P
Pharmaceuticals
344 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
172
Activity (Last 30 Days)
7
5
1
4
7
1
3
2
1
4
1
5
6
1
5
4
2
2
4
4
4
5
2026-03-052026-04-02
Top Publishers
Stat News167 stories
Reason Magazine3 stories
CNBC2 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|3/27/2026
UNVERIFIEDSingle Source
STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout
Stat News|3/26/2026
UNVERIFIEDSingle Source
STAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: The potential loophole in Trump’s plan to get other countries to pay more for drugs
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: This bill could make CVS choose between its stores and its pharmacy benefit manager
Stat News|3/23/2026
UNVERIFIEDSingle Source
STAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugs
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Novartis picks up experimental breast cancer therapy for $2B
Stat News|3/20/2026
UNVERIFIEDSingle Source
Drug development is booming in China. Should the U.S. view it as a threat or an opportunity?
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: J&J wins approval for first-of-its-kind psoriasis pill
Stat News|3/18/2026
UNVERIFIEDSingle Source
How STAT would cover ‘The Fugitive’ if its pharma scandal were real
Stat News|3/13/2026
UNVERIFIEDSingle Source
STAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback
Stat News|3/11/2026
UNVERIFIEDSingle Source
STAT+: Large drugmakers are developing fewer antibiotics, analysis finds
Stat News|3/10/2026
UNVERIFIEDSingle Source
STAT+: Vertex says its drug successfully reduced marker of kidney disease in late-stage trial
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B
Stat News|3/6/2026
UNVERIFIEDSingle Source
We Lost the Lyme Vaccine. Under Rand Paul's New Vaccine Liability Bill, We'll Lose More.
Reason Magazine|3/5/2026
UNVERIFIEDSingle Source
STAT+: The extremism of the FDA’s Marks and Prasad has come with costs
Stat News|3/5/2026
UNVERIFIEDSingle Source
STAT+: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Justice Department backs AbbVie in its bid to overturn a Colorado law guiding a drug discount program
Stat News|2/26/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy
Stat News|2/19/2026
UNVERIFIEDSingle Source
The FDA Talks Over-the-Counter Freedom. Big Pharma Profits From Keeping It Restricted.
Reason Magazine|2/19/2026
UNVERIFIEDSingle Source
STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance
Stat News|2/18/2026
UNVERIFIEDSingle Source
STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions
Stat News|2/17/2026
UNVERIFIEDSingle Source
Opinion: When IV opioids are in short supply at the hospital, who gets pain relief?
Stat News|2/17/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|2/13/2026
UNVERIFIEDSingle Source
Opinion: My granddaughter has a rare disease. But clinical trials often exclude patients like her
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
Stat News|2/7/2026
UNVERIFIEDSingle Source
STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Roivant immune drug significantly outperformed placebo in treating rare skin disease
Stat News|2/6/2026
UNVERIFIEDSingle Source
Statins don’t cause most of the side effects on package warnings, study finds
Stat News|2/5/2026
UNVERIFIEDSingle Source
Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s
Stat News|2/5/2026
UNVERIFIEDSingle Source
A sneak peek of pharma’s Super Bowl ads: GLP-1s, tight ends, and more
Stat News|2/5/2026
UNVERIFIEDSingle Source
New PBM law could open door to direct sales between employers, drugmakers
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Pfizer moves forward with its hopes for a monthly obesity drug
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026